Skip to main content

Bioanalysis Zone is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Awards
  • Events
  • Features
    • An author's perspective
    • Ask the Experts
    • Conference reports
    • eBooks
    • Expert opinion
    • In the Zone
    • Journal articles
    • Journal content
    • Spotlights
    • Tech Digest

    Follow us on social media

  • Glossary
  • Topics
    • Applications
      • Advanced therapies
      • Biomarkers
      • Clinical
      • Diagnostics
      • Drug development
      • Forensics
      • Patient-centric sampling
      • Sports drug testing
      • Toxicology
      • Vaccines
    • Industry updates & regulations
      • Biopharmaceuticals
      • Collaborations & mergers
      • Data processing and interpretation
      • Regulated bioanalysis
    • Molecules
      • Antibodies | ADCs
      • Biosimilars
      • Large molecules
      • Metabolites
      • Oligonucleotides
      • Small molecules
    • Techniques
      • Automation
      • Chromatography
      • Imaging
      • LBA
      • Microsampling
      • MS (LC–MS/MS, HRMS, IMS)
      • Sample preparation

    Follow us on social media

  • Multimedia
    • Coffee chats
    • Infographics
    • Interviews
    • Panel discussions
    • Podcasts
    • Videos
    • Webinars

    Follow us on social media

  • News
  • Partners
  • Register
WEBINAR | Mastering B-cell biomarker tracking in autoimmune therapy 12 days 22 hours 41 mins 31 secs SAVE YOUR SEAT!

Proteomics infographic

4 Mar 2019
General interest

As part of our mini-Spotlight on proteomics, we carried out a survey to gain an insight into the trends, challenges and developments associated with proteomics R&D. We would like to thank everyone who was able to share their thoughts by taking part in the survey – you can see the results below in our infographic.

Proteomics infographic web-01

Top content

  • New-generation ADCs redefine treatment for HER2-positive breast cancer
  • How blockchain and AI are transforming data integrity in bioanalysis
  • Onsite media partners confirmed for PharmSci 360 2025

Related tags

infographic proteomics Spotlight Survey
Previous article Next article

Related articles

1 APR 2011 CLINICAL
Making the cut: untangling clinical protein biomarker discovery and validation
8 OCT 2018 DATA PROCESSING AND INTERPRETATION
Top 5 tips to set-up and run any flow cytometry assay
15 SEP 2015 CHROMATOGRAPHY
Nano-LC in proteomics: recent advances and approaches
12 MAR 2025 NEWS
The antibody avengers and the norovirus vaccine
30 JUN 2009 CHROMATOGRAPHY
Recent progress in selected reaction monitoring MS-driven plasma protein biomarker analysis
10 APR 2019 ADVANCED THERAPIES
Cell and gene therapy infographic
  • About
  • Advertising & Sponsorship
  • Learn
    • Awareness
    • Education zone
    • Professional development
  • Contact Us
  • Permissions
  • Products
  • Zone Leaders
  • Whitelist Emails
  • Accessibility

Contact

Contact Us

Office info

Bioanalysis Zone is powered by Taylor & Francis Group

Bioanalysis Zone, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2025 Bioanalysis Zone